Alcives Avila-Sorrosa

Prof. Dr. Alcives Avila-Sorrosa

Organic Chemistry, Instituto Politécnico Nacional, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MSMizraín Solares-Briones
Mizraín Solares-Briones
GCGuadalupe Coyote-Dotor
Guadalupe Coyote-Dotor
JFJosé Carlos Páez Franco
José Carlos Páez Franco
MZMiriam R. Zermeño-Ortega
Miriam R. Zermeño-Ortega
CCCarmen Myriam de la O Contreras
Carmen Myriam de la O Contreras
Juan Manuel Germán-AcacioJuan Manuel Germán-Acacio
Juan Manuel Germán-Acacio
Mechanochemistry is considered an alternative attractive greener approach to prepare diverse molecular compounds and has become an important synthetic tool in different fields (e.g., physics, chemistry, and material science) since is considered an ecofriendly procedure that can be carried out under solvent free conditions or in the presence of minimal quantities of solvent (catalytic amounts). Being able to substitute, in many cases, classical solution reactions often requiring significant amounts of solvents. These sustainable methods have had an enormous impact on a great variety of chemistry fields, including catalysis, organic synthesis, metal complexes formation, preparation of multicomponent pharmaceutical solid forms, etc. In this sense, we are interested in highlighting the advantages of mechanochemical methods on the obtaining of pharmaceutical cocrystals. Hence, in this review, we describe and discuss the relevance of mechanochemical procedures in the formation of multicomponent solid forms focusing on pharmaceutical cocrystals. Additionally, at the end of this paper, we collect a chronological survey of the most representative scientific papers reporting the mechanochemical synthesis of cocrystals.

11 February 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JFJosé Carlos Páez Franco
José Carlos Páez Franco
MZMiriam R. Zermeño-Ortega
Miriam R. Zermeño-Ortega
COCarmen Myriam de la O-Contreras
Carmen Myriam de la O-Contreras
DCDaniel Canseco-González
Daniel Canseco-González
JUJesus Ricardo Parra Unda
Jesus Ricardo Parra Unda
DAVID MORALES-MORALESDAVID MORALES-MORALES
DAVID MORALES-MORALES
Fluorination of pharmaceutical agents has afforded crucial modifications to their pharmacological profiles, leading to important advances in medicinal chemistry. On the other hand, metallodrugs are considered to be valuable candidates in the treatment of several diseases, albeit with the caveat that they may exhibit pharmacological disadvantages, such as poor water solubility, low bioavailability and short circulating time. To surmount these limitations, two approaches have been developed: one based on the design of novel metallodrug-delivering carriers and the other based on optimizing the structure of the ligands bound to the metal center. In this context, fluorination of the ligands may bring beneficial changes (physicochemical and biological) that can help to elude the aforementioned drawbacks. Thus, in this review, we discuss the use of fluorinated ligands in the design of metallodrugs that may exhibit potential anticancer activity.

1 April 2010 in Inorganica Chimica Acta
Verified
Journal Article
Closed access
AAAlcives Avila-Sorrosa
Alcives Avila-Sorrosa
FEFabiola Estudiante-Negrete
Fabiola Estudiante-Negrete
SHSimón Hernández-Ortega
Simón Hernández-Ortega
RTRUBEN A. TOSCANO
RUBEN A. TOSCANO
DAVID MORALES-MORALESDAVID MORALES-MORALES
DAVID MORALES-MORALES

1 April 2015 in Journal of Molecular Structure
Verified
Journal Article
Closed access
AAAlcives Avila-Sorrosa
Alcives Avila-Sorrosa
JHJorge Ignacio Hernández-González
Jorge Ignacio Hernández-González
ARAlicia Reyes-Arellano
Alicia Reyes-Arellano
RTRUBEN A. TOSCANO
RUBEN A. TOSCANO
RRReyna Reyes-Martínez
Reyna Reyes-Martínez
DAVID MORALES-MORALESDAVID MORALES-MORALES
DAVID MORALES-MORALES

24 August 2019 in Molecules
Verified
Journal Article
Open access
PDF file
AAAlcives Avila-Sorrosa
Alcives Avila-Sorrosa
JTJazz D. Tapia-Alvarado
Jazz D. Tapia-Alvarado
BTBenjamin Nogueda Torres
Benjamin Nogueda Torres
KCKarla Fabiola Chacón-Vargas
Karla Fabiola Chacón-Vargas
FDFrancisco Díaz-Cedillo
Francisco Díaz-Cedillo
DAVID MORALES-MORALESDAVID MORALES-MORALES
DAVID MORALES-MORALES
A series of 2-benzylsulfanyl benzothiazole (BTA) derivatives were synthesized and fully characterized and in vitro tested against two strains of T. cruzi (NINOA and INC-5), exhibiting good activities at low concentrations.

1 December 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Open access
ABAlejandro Bucio-Cano
Alejandro Bucio-Cano
ARAlicia Reyes-Arellano
Alicia Reyes-Arellano
JCJosé Correa-Basurto
José Correa-Basurto
MBMartiniano Bello
Martiniano Bello
JTJenifer Torres-Jaramillo
Jenifer Torres-Jaramillo
AAAlcives Avila-Sorrosa
Alcives Avila-Sorrosa
To counteract bacterial resistance, we investigated the interruption of quorum sensing mediated by non-classical bioisosteres of the N-hexanoyl homoserine lactone with an azoline core. For this purpose, a set of selected 2-substituted azolines was synthesized, establishing the basis for a new protocol to synthesize 2-amino imidazolines. The synthesized compounds were evaluated as inhibitors of violacein production in Chromobacterium violaceum. Theoretical studies on bioisostere-protein interactions were performed using CviR. The results show that some azolines decreased violacein production, suggesting an antiquorum sensing profile against Gram-negative bacteria. Docking and molecular dynamic simulations together with binding free energy calculations revealed the exact binding and inhibitory profiles. These theoretical results show relationship with the in vitro activity of the azoline series.